About 2,270,000 results
Open links in new tab
  1. Medical Treatment Options for Diseases & Conditions - Drugs.com

    Find your disease or condition and discover what medication options are available for you. Sort drugs by popularity, reviews and ratings.

  2. Novel Drug Approvals for 2025 | FDA

    Dec 4, 2025 · Novel Drug Approvals for 2025 What are "Novel" Drugs? "Novel" drugs are new drugs never before approved or marketed in the U.S.

  3. 6 Rare Diseases That Have New FDA-Approved Treatments

    Feb 28, 2025 · An estimated 7,000 of these conditions have been identified, and more than 90% of them have no FDA-approved treatment. Yet progress toward developing such treatments …

  4. What's new in drug therapy - UpToDate

    Nov 21, 2025 · In August 2025, the US Food and Drug Administration approved semaglutide for treatment of MASH [57]. (See "Management of metabolic dysfunction-associated steatotic liver …

  5. Aldeyra Therapeutics Announces PDUFA Extension of the New Drug ...

    6 hours ago · About Aldeyra Aldeyra Therapeutics is a biotechnology company devoted to discovering innovative therapies designed to treat immune-mediated diseases.

  6. FDA approves first new antibiotics to treat gonorrhea in decades …

    4 days ago · For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually …

  7. 6 Graves’ Disease Drugs in Late-stage Development

    Jan 24, 2025 · The pipeline for Graves’ disease drug treatments is rapidly expanding, with prominent companies such as I mmunovant, Viridian Therapeutics, Argenx, Tourmaline Bio, …

  8. Shining Light on How Protagonist, Takeda Drug Brings Treatment

    Dec 7, 2025 · A drug from partners Protagonist Therapeutics and Takeda Pharmaceutical offers the promise of a therapeutic intervention for one of these rare blood diseases, polycythemia vera.

  9. ASH: Novartis details ianalumab's phase 3 rare blood disease win

    6 days ago · ORLANDO, Fla.—Novartis is divulging details from ianalumab’s summertime phase 3 win in a rare autoimmune blood disorder, and the data suggest the treatment could delay the …

  10. Top Rare Disease Treatment Companies in Global 2025 | Global …

    Jun 12, 2025 · USA Growing Rare Disease Treatment Market The United States continues to dominate the global rare disease treatment landscape in 2025, driven by advanced healthcare …